NIH pinpoints cause for fatal hepatitis b-related liver disease
Scientists have honed in on the cause of a rare condition Hepatitis B virus-associated acute liver failure that can kill a patient in a few days. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 15, 2018 Category: Consumer Health News Source Type: news

Medical News Today: The connection between cirrhosis and hepatitis C
The liver is a powerful organ that the hepatitis C virus can affect. The virus causes inflammation and can lead to scarring. The name for scarring of the liver is cirrhosis. People with both conditions may have more risk of liver failure. Learn more about the link between hepatitis C and cirrhosis here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 15, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Liver Disease Risk Factors in Patients Treated for Alcohol and Drug Dependence
Conclusion As this was only a pilot study, further data collection involving a larger, representative sample of clients should be undertaken to explore these results further. References Bennett, H. et al., 2015. Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections. PLoS ONE, 10(5), p.e0125846. Edeghere, O. et al., 2015. Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection. Public Health, 129(5), pp.509–5...
Source: Alcohol Research UK - November 15, 2018 Category: Addiction Authors: admin Tags: Alcohol Insights Source Type: news

Omega-3 fatty acids found to control non-alcoholic fatty liver disease
(Natural News) It is a little-known fact that even teetotalers can end up with liver disease. In fact, the most common form of this type of disease in the United States – non-alcoholic fatty liver disease (NAFLD) – affects close to 100 million people and can affect even those who drink little or no alcohol.... (Source: NaturalNews.com)
Source: NaturalNews.com - November 15, 2018 Category: Consumer Health News Source Type: news

Liver Fat Scores Predict Liver Disease Mortality in the US Liver Fat Scores Predict Liver Disease Mortality in the US
This study examined how markers of liver health are associated with mortality in persons without viral hepatitis in the United States. Are liver fat scores useful for metabolic health surveillance?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

UMN researchers discover important connection between cells in the liver
(University of Minnesota Medical School) University of Minnesota Medical School researchers have made a discovery which could lead to a new way of thinking about how disease pathogenesis in the liver is regulated, which is important for understanding the condition nonalcoholic fatty liver disease (NAFLD), which is incredibly common and growing. It is apparent that about 30 percent of Americans and are at risk to advance to more severe conditions such as nonalcoholic steatohepatitis (NASH), cirrhosis, cardiovascular disease, or even liver cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 15, 2018 Category: International Medicine & Public Health Source Type: news

Infants born to obese mothers risk developing liver disease, obesity
(University of Colorado Anschutz Medical Campus) Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers at the University of Colorado Anschutz Medical Campus. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 15, 2018 Category: Biology Source Type: news

Medical News Today: What to know about hepatitis C in men
Hepatitis C is a viral illness that affects the liver. Men tend to experience it at higher rates than women, but it is unclear why. Some people believe that it may be due to estrogen ’s protective effect. Diagnosis and testing can help people find treatment. Learn more about hepatitis C in men here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 14, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Medical News Today: What to know about late-stage hepatitis C
Hepatitis C is a viral infection that can cause substantial liver damage, particularly in the later stages. The treatment and outlook will depend on the progression of the disease. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 14, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Multiple Drugs Advance for Fatty Liver Disease Multiple Drugs Advance for Fatty Liver Disease
Drugs that act on different pathways in nonalcoholic steatohepatitis are showing progress, but a cure is still elusive, researchers report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

New way to monitor diabetes and other metabolic disorders
EU-funded researchers have developed computer models that accurately predict and monitor the progression of metabolic syndrome and its associated diseases. This advance may result in new therapies for diabetes, hyperlipidemia, liver disease and more. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 13, 2018 Category: Research Source Type: news

Do Patients with Chronic Liver Disease Face Higher DILI Risk?
(MedPage Today) -- Research suggests a link of which drug developers should be aware, expert says (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 12, 2018 Category: Gastroenterology Source Type: news

Hospitalization Costs for High-Need Patients With GI Diseases Hospitalization Costs for High-Need Patients With GI Diseases
This study analyzed the annual burden and costs of hospitalization in patients with chronic GI and liver disease. Which patients are at high risk for frequent hospitalizations and long hospital stays?Clinical Gastroenterology and Hepatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 12, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Researchers identify risk factors of advanced liver disease in cystic fibrosis patients
(Children's Hospital Colorado) Children's Hospital Colorado (Children's Colorado) pediatric gastroenterologist, Michael Narkewicz, MD, recently shared results of the Prospective Study of Ultrasound to Predict Hepatic Cirrhosis in Cystic Fibrosis (PUSH), which sought to determine if liver ultrasounds could identify children and adolescents with cystic fibrosis who are at greater risk of developing advanced liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 12, 2018 Category: International Medicine & Public Health Source Type: news

Should You Take Aspirin Every Day? Here ’s What the Science Says
Aspirin is best known as an over-the-counter painkiller. But acetylsalicylic acid, as it’s called chemically, has many other health benefits, as well as side effects, in the body that have only become clear in recent years. Here’s what the latest science says about the health benefits and side effects of aspirin, as well as which conditions it may treat and those it doesn’t appear to improve. (If you are taking aspirin for any reason other than for periodic pain relief, it’s best to consult with your doctor to confirm whether the benefits outweigh the risks in your particular case.) How aspirin affe...
Source: TIME: Health - November 8, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthytime Source Type: news

Elastography helps diagnose pediatric liver fibrosis
Transient elastography is an effective diagnostic tool for identifying liver...Read more on AuntMinnie.comRelated Reading: Elastography, MRI effective for detecting liver lesions Ultrasound elastography helps identify invasive breast cancer Shear-wave elastography works to evaluate liver disease SWE helps characterize suspicious breast masses Steatosis complicates MR elastography for liver fibrosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 6, 2018 Category: Radiology Source Type: news

The Misunderstood Coagulopathy of Liver Disease The Misunderstood Coagulopathy of Liver Disease
An elevated INR is commonly considered an indication of bleeding risk in patients with liver disease, but is this practice supported by the evidence?Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2018 Category: Consumer Health News Tags: Emergency Medicine Journal Article Source Type: news

Researchers find novel mutation affecting YARS causes multisystem disease
(Clinic for Special Children) Researchers have identified a novel missense mutation in tyrosyl-tRNA synthetase (YARS c.499C>A, p.Pro167Thr) that causes a severe recessive disorder in affected individuals. The report includes detailed clinical characterization of seven related Amish children who were homozygous for the variant. The children all exhibited poor growth, developmental delay, abnormal brain white matter, hearing loss, involuntary eye movements, progressive cholestatic liver disease, pancreatic insufficiency, hypoglycemia, anemia, intermittent excess of protein in urine, recurrent bloodstream infections, and c...
Source: EurekAlert! - Medicine and Health - November 6, 2018 Category: International Medicine & Public Health Source Type: news

A natural remedy for alcohol-induced fatty liver disease found in licorice root
(Natural News) Drinking alcohol has become a major part of people’s social lives. People drink when they are happy, sad, stressed, or feeling any other emotion. There is some benefit to moderate drinking, but too much can harm a person’s health. In particular, this can lead to a condition called alcohol-induced fatty disease. A study in BMC... (Source: NaturalNews.com)
Source: NaturalNews.com - November 5, 2018 Category: Consumer Health News Source Type: news

What you should be eating to avoid liver disease
(Natural News) The liver, which is the largest organ in the body, plays various important roles in the metabolic processes of the body, including filtering toxins from the blood and converting food to energy. Therefore, it is important to take the steps to improve liver health and avoid liver disease. You can improve liver health... (Source: NaturalNews.com)
Source: NaturalNews.com - November 4, 2018 Category: Consumer Health News Source Type: news

Fatty Liver Disease in the Spotlight at The Liver Meeting Fatty Liver Disease in the Spotlight at The Liver Meeting
Current and future treatments for fatty liver disease, particularly nonalcoholic steatohepatitis, the most prevalent liver disease in the United States, will be explored at The Liver Meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Medical News Today: Is there a vaccine for hepatitis C?
While vaccines exist for hepatitis A and B, researchers are still developing a vaccine for hepatitis C. Learn more about future treatments in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 31, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Recent research suggests that even low exposure to glyphosate can contribute to liver damage
(Natural News) Back in 2015, the American Liver Foundation estimated that at least one in four Americans was living with non-alcoholic fatty liver disease (NAFLD), an illness that can affect even those who drink little or no alcohol. People in their 40s and 50s are most vulnerable, especially those who carry extra weight around their... (Source: NaturalNews.com)
Source: NaturalNews.com - October 29, 2018 Category: Consumer Health News Source Type: news

Novartis, Pfizer join forces on potentially lucrative fatty liver disease
Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics. (Source: Reuters: Health)
Source: Reuters: Health - October 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Interleukin IL-22, a new target to inhibit the progression of liver disease
(University of Montreal Hospital Research Centre (CRCHUM)) Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease. They have characterized the mechanisms of action of type 3 inflammatory cytokines that are produced by the cells of the immune system, which result in a progression of hepatic scarring known as fibrosis. These research efforts have identified new potential targets to inhibit the progression of liver disease and prevent cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 26, 2018 Category: International Medicine & Public Health Source Type: news

Medical News Today: What is the difference between hepatitis B and C?
Hepatitis B and hepatitis C are both infections that cause inflammation of the liver. While they have similar symptoms, they also have a few key differences, including their transmission, the duration of the infection, and what treatments are available. Learn more about the differences in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 25, 2018 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Clues to the link between obesity and liver cancer-and identification of a new risk group
(Monash University) New research has found a previously overlooked group of obese people may be at risk of developing deadly liver cancer. Most obese individuals who develop liver cancer first develop non-alcoholic fatty liver disease, and then the more severe non-alcoholic steatohepatitis. This can lead to cirrhosis and liver failure. However, this research reveals pathways to the development of liver cancer in obese people that are not reliant on the development of non-alcoholic steatohepatitis or cirrhosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 25, 2018 Category: Cancer & Oncology Source Type: news

Expert panel urges hepatitis A shots for homeless in U.S.
This is the first time a routine vaccination has been recommended for homeless persons. Officials hope to prevent future outbreaks of the contagious liver disease. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 24, 2018 Category: Consumer Health News Authors: Lena H. Sun Source Type: news

US advisory group urges hepatitis A shots for homeless
For the first time, a U.S. advisory committee is recommending a routine vaccination for homeless people, voting Wednesday to urge hepatitis A shots for the homeless to prevent future outbreaks of the contagious liver disease (Source: ABC News: Health)
Source: ABC News: Health - October 24, 2018 Category: Consumer Health News Tags: Health Source Type: news

Risk of HCC in NASH Compared to Other Liver Diseases Risk of HCC in NASH Compared to Other Liver Diseases
What is the pooled risk of hepatocellular carcinoma, as compared to other liver diseases, in patients with NASH with and without cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 24, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Shellfish and tea? Compounds found in both protect you from a progressive form of nonalcoholic fatty liver disease
(Natural News) Sipping tea in between mouthfuls of taurine-rich shellfish sounds like a strange combination. However, Chinese researchers say this is an excellent way to protect your liver from certain diseases. Their new study shows that the combination of taurine and tea polyphenols can prevent the onset of nonalcoholic steatohepatitis (NASH). NASH is the progressive... (Source: NaturalNews.com)
Source: NaturalNews.com - October 24, 2018 Category: Consumer Health News Source Type: news

Liver fat can be quickly and significantly reduced with a gastrointestinal hormone
(Natural News) A study published in The Lancet reported that NGM282, a non-tumorigenic variant of a hormone found in the gastrointestinal tract, was able to reduce the liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). According to researchers, the findings demonstrated the potential of the compound to be used in treating both... (Source: NaturalNews.com)
Source: NaturalNews.com - October 24, 2018 Category: Consumer Health News Source Type: news

Sarcopenia in Liver Disease Sarcopenia in Liver Disease
Patients with end-stage liver disease are at an increased risk of developing sarcopenia; however, early recognition and management prior to liver transplantation may improve post-transplant outcomes.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 22, 2018 Category: Consumer Health News Tags: Gastroenterology Expert Column Source Type: news

10 Ways to Keep Your Heart Healthy
No one ever had fun visiting the cardiologist. ­Regardless of how good the doc might be, it’s always a little scary thinking about the health of something as fundamental as the heart. But there are ways to take greater control—to ensure that your own heart health is the best it can be—even if you have a family history of cardiovascular disease. Although 50% of cardiovascular-disease risk is genetic, the other 50% can be modified by how you live your life, according to Dr. Eugenia Gianos, director of Women’s Heart Health at Lenox Hill Hospital in New York City. “This means you can greatly ...
Source: TIME: Health - October 17, 2018 Category: Consumer Health News Authors: Lisa Lombardi and Jamie Ducharme Tags: Uncategorized Baby Boomer Health heart health Source Type: news

Sleeping beauty helps identify genes involved in a fatty liver-associated liver cancer
(Osaka University) Hepatocellular carcinoma, a deadly form of liver cancer, is increasingly being linked to non-alcoholic fatty liver disease; however, the underlying genetic mechanism of disease progression had remained unknown. Using a Sleeping Beauty mutagenesis screen, Osaka University researchers found that Sav1 and downstream components of the Hippo signaling pathway are drivers of the development of liver cancer associated with fatty liver disease. These findings pave the way for liver cancer treatments targeting the Hippo pathway. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

Web-Based Lifestyle Program Works for Liver Disease Patients
TUESDAY, Oct. 16, 2018 -- Web-based programs may be effective in helping patients make lifestyle changes to control non-alcoholic fatty liver disease (NAFLD), according to a study published in the November issue of the Journal of Hepatology. Arianna... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2018 Category: Pharmaceuticals Source Type: news

Diving for Data
Discussion around this is definitely part of the public discourse now but this is going to turn slowly like an ocean liner as incentives become more aligned.“The reimbursement of volume-based agreements is such a complex calculation to unwind, and people acknowledge that it is sensible but a hard thing to do. It takes a lot to move people off tried-and-true, low-risk ways of measuring the performance of a drug.Related Content: Rid Yourself Of Dirty DataTalking The Same LanguageNavigating the ChaosSeeking the Holy Grail of RWEThe Naked Truth About Outcomes-Based PricingPrimary Event: Value Summit USA 2018Pr ...
Source: EyeForPharma - October 16, 2018 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Alcohol-related liver disease patients need more care, study finds
(University of Edinburgh) Patients with alcohol-related liver disease (ALD) tend to have worse outcomes than others following a stay in intensive care, research shows. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 15, 2018 Category: International Medicine & Public Health Source Type: news

Vital Therapies Evaluating Options After Clinical Trial Failure
Vital Therapies is reviewing strategic options including a potential sale or merger of the company, according to an SEC filing. The decision to review its position comes after the San Diego-based company failed to meet the endpoints in a clinical trial evaluating its cell-based ELAD System, designed to treat patients suffering from liver disease. In addition to the potential sale or merger, the company said it would reduce the number of people serving on its board from nine to four members. The firm said it has retained Ladenburg Thalmann & Co. Inc. as its strategic financial advisor. Vital Therapies' ELAD ...
Source: MDDI - October 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Modest Alcohol Consumption May Reduce Mortality in NAFLD
FRIDAY, Oct. 12, 2018 -- For patients with nonalcoholic fatty liver disease (NAFLD), modest alcohol consumption is associated with a reduction in all-cause mortality, while drinking 1.5 or more drinks per day may increase mortality, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 12, 2018 Category: Pharmaceuticals Source Type: news

NIH awards Steve Farber $3.3-million to identify medicines for cardiovascular disease
(Carnegie Institution for Science) Carnegie's Department of Embryology scientist Steven Farber and team have been awarded a 5-year $3.3-million NIH grant to identify novel pharmaceuticals for combatting a host of diseases associated with altered levels of lipoproteins like LDL ('bad cholesterol'). Obesity, diabetes, cardiovascular disease, fatty liver disease, and metabolic syndrome have all been linked to changes in plasma lipoproteins. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2018 Category: International Medicine & Public Health Source Type: news

Cleanse your liver with these natural herbs
(Natural News) Anyone can develop liver disease, even if you don’t frequently drink alcohol. To maintain your overall health, you can take herbal supplements that can help cleanse your liver. What exactly does the liver do? The liver has various functions. It produces various chemicals that the body needs to function normally and it breaks... (Source: NaturalNews.com)
Source: NaturalNews.com - October 7, 2018 Category: Consumer Health News Source Type: news

South Africa:World's First Intentional HIV+ Liver Transplant
[Wits University] Wits doctors transplanted the liver from a mother living with HIV to her critically ill HIV negative child, who had end-stage liver disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 5, 2018 Category: African Health Source Type: news

Obesity, Weight Gain Linked to Fibrosis Progression in NAFLD Obesity, Weight Gain Linked to Fibrosis Progression in NAFLD
Obesity and weight gain were independently associated with an increased risk for fibrosis progression in patients with nonalcoholic fatty liver disease (NAFLD), a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Cleanse your liver with these natural herbs
(Natural News) Anyone can develop liver disease, even if you don’t frequently drink alcohol. To maintain your overall health, you can take herbal supplements that can help cleanse your liver. What exactly does the liver do? The liver has various functions. It produces various chemicals that the body needs to function normally and it breaks... (Source: NaturalNews.com)
Source: NaturalNews.com - October 4, 2018 Category: Consumer Health News Source Type: news

Novel and Emerging Therapies for Cholestatic Liver Diseases Novel and Emerging Therapies for Cholestatic Liver Diseases
A better understanding of the pathophysiology of cholestatic liver diseases has led to the development of more targeted treatment options. Find out what's new.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Would you rather die of liver failure or live with HIV?
(University of the Witwatersrand) In 2017, doctors from the Transplant Unit at the Wits Donald Gordon Medical Centre performed what is believed to be the world's first intentional liver transplant from a mother living with HIV to her critically ill HIV negative child, who had end-stage liver disease. Now, more than a year later, the mother and child have fully recovered, however, doctors are unsure the HIV-status of the child. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 4, 2018 Category: Infectious Diseases Source Type: news

New study evaluates efficacy of PET imaging to manage chronic liver diseases
(Society of Nuclear Medicine and Molecular Imaging) While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications. These effects may soon be a thing of the past for some patients thanks to new research showing PET imaging with the 18F-FAC radiotracer can be used as a non-invasive substitute. The study is featured in the October issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 4, 2018 Category: International Medicine & Public Health Source Type: news

Prevent liver fibrosis with TCM
(Natural News) According to research findings, the key to treating liver fibrosis may be found in a traditional herbal formula. The study, which was published in BMC Complementary and Alternative Medicine, showed that Traditional Chinese Medicine (TCM) may help reduce the risk of liver disease. Liver fibrosis is a wound-healing process that occurs when the body sustains chronic liver... (Source: NaturalNews.com)
Source: NaturalNews.com - October 3, 2018 Category: Consumer Health News Source Type: news

NY woman refused to accept her liver failure until it caused vitiligo
Julie Williams, 22, from New York, was diagnosed with the progressive liver disease primary sclerosing cholangitis in 2014 after she started to develop itching on the bottom of her feet. (Source: the Mail online | Health)
Source: the Mail online | Health - October 2, 2018 Category: Consumer Health News Source Type: news